Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma

被引：0
|
作者：
Joo Hyun Kim
Won Seog Kim
Chaehwa Park
机构：
[1] Sungkyunkwan University,Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology
[2] Sungkyunkwan University School of Medicine,Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center
[3] Sungkyunkwan University School of Medicine,Research Institute for Future Medicine, Samsung Medical Center
来源：
BMC Cancer | / 19卷
关键词：
Lymphoma; PI3K; Copanlisib; Duvelisib; Drug resistance; IL-6;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphoma
    Kim, Joo Hyun
    Kim, Won Seog
    Park, Chaehwa
    [J]. BMC CANCER, 2019, 19 (01)
  • [2] Chemokine to the Rescue: Interleukin-8 Mediates Resistance to PI3K-Pathway-Targeted Therapy in Breast Cancer
    Abraham, Robert T.
    [J]. CANCER CELL, 2012, 22 (06) : 703 - 705
  • [3] p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer
    Eichhom, Pieter J. A.
    Serra, Violeta
    Garcia-Garcia, Celina
    Ibrahim, Yasir H.
    Prudkin, Lumilla
    Parra, Josep-Lluis
    Prat, Aleix
    Hahn, William C.
    Kim, So Young
    Baselga, Jose
    [J]. MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [4] Interleukin-6 signaling pathway in targeted therapy for cancer
    Guo, Yuqi
    Xu, Feng
    Lu, Tianjian
    Duan, Zhenfeng
    Zhang, Zhan
    [J]. CANCER TREATMENT REVIEWS, 2012, 38 (07) : 904 - 910
  • [5] p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer.
    Serra, Violeta
    Eichhorn, Pieter J. A.
    Garcia-Garcia, Celina
    Ibrahim, Yasir
    Prudkin, Ludmila
    Rodriguez, Olga
    Marlow, Sara
    Prat, Aleix
    Hahn, William C.
    Baselga, Jose
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [6] PI3K blockade reverses primary resistance and adaptation to eribulin in PI3K-pathway activated breast cancer tumors
    Gris-Oliver, A.
    Saura, C.
    Oliveira, M.
    Piris, A.
    Nuciforo, P.
    Perez-Garcia, J.
    Arribas, J.
    Baselga, J.
    Cortes, J.
    Serra, V.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 61 : S123 - S123
  • [7] Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer
    Dijkgraaf, Eveline M.
    Welters, Marij J. P.
    Nortier, Johan W. R.
    van der Burg, Sjoerd H.
    Kroep, Judith R.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (25) : 3816 - 3827
  • [8] Molecular neuropathology and Pi3K-pathway activation in epilepsy-associated glioneuronal lesions
    Majores, M.
    [J]. ACTA NEUROPATHOLOGICA, 2007, 114 (03) : 319 - 319
  • [9] PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma
    Vladimir Sapon-Cousineau
    Sasha Sapon-Cousineau
    Sarit Assouline
    [J]. Current Treatment Options in Oncology, 2020, 21
  • [10] PI3K Inhibitors and Their Role as Novel Agents for Targeted Therapy in Lymphoma
    Sapon-Cousineau, Vladimir
    Sapon-Cousineau, Sasha
    Assouline, Sarit
    [J]. CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (06)
12345